Key clinical findings include: Gallbladder events were observed throughout the treatment period The FDA recommends informing patients of characteristic symptoms of cholelithiasis and cholecystitis If cholelithiasis is suspected, appropriate clinical evaluation and treatment are indicated Patients generally responded to standard medical or surgical management Clinicians should interpret these data within the broader context of tirzepatide's substantial metabolic benefits, including significant improvements in glycemic control, cardiovascular risk factors, and weight-related comorbidities, while maintaining appropriate vigilance for gallbladder complications
PMID: 38356208
Try not to let worry take away from the positive step you are taking for your health
After reviewing your medical history, BMI, and health goals, a licensed provider will determine whether treatment is appropriate and recommend the best option for you
Additionally, the low bioavailability of PCs, primarily due to poor gastrointestinal absorption, poses challenges for clinical application
See our BPC-157 storage guide for a concrete example of how this works in a multi-vial protocol
